2020
The Impact of COVID‐19 on Organ Donation, Procurement, and Liver Transplantation in the United States
Merola J, Schilsky ML, Mulligan DC. The Impact of COVID‐19 on Organ Donation, Procurement, and Liver Transplantation in the United States. Hepatology Communications 2020, 5: 5-11. PMID: 33043228, PMCID: PMC7537114, DOI: 10.1002/hep4.1620.Peer-Reviewed Original ResearchLiver transplantationOrgan recoveryOrgan transplantationSevere acute respiratory syndrome coronavirus type 2End-stage liver diseaseOrgan donationExpected excellent outcomesLiver transplant recipientsCoronavirus disease 2019 (COVID-19) pandemicCoronavirus type 2Life-saving procedureCoronavirus disease 2019Disease 2019 pandemicOrgan procurement organizationsHealth care systemTransplant recipientsOrgan failureLiver diseaseDonor evaluationExcellent outcomesDisease 2019New practice paradigmHospital resourcesType 2Particular patient
2009
ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation
Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D’Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB, Committee T. ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation. American Journal Of Transplantation 2009, 9: 2004-2011. PMID: 19624569, DOI: 10.1111/j.1600-6143.2009.02739.x.Peer-Reviewed Original ResearchConceptsOrgan donationFavorable posttransplant outcomesOrgan acceptance criteriaOrgan procurement organizationsBrain death criteriaBiliary issuesDCD kidneysPancreas transplantationVentilatory supportPosttransplant outcomesCardiac deathTransplant centersIschemia timeDCD protocolsHopeless prognosisMachine perfusionBrain deathTransplant surgeonsOperative techniqueOrgan transplantationPractice guidelinesBest practice guidelinesOrgan procurementDonor characteristicsTransplantation
2003
Effects of tacrolimus on ischemia‐reperfusion injury
St. Peter SD, Moss AA, Mulligan DC. Effects of tacrolimus on ischemia‐reperfusion injury. Liver Transplantation 2003, 9: 105-116. PMID: 12548502, DOI: 10.1053/jlts.2003.50020.Peer-Reviewed Original ResearchConceptsEffects of tacrolimusIschemia-reperfusion injuryCellular mechanismsCalcium-activated pathwaysInteractions of tacrolimusFree radical metabolismCornerstone agentEfficacious immunosuppressionInflammatory cascadeOrgan transplantationTacrolimusCytoprotective effectsTissue recoveryClinical literatureDiverse actionsRadical metabolismImmunosuppressionInjuryMitochondrial stabilityStress response proteinsReperfusionIschemiaTransplantationTranscription factorsMicrocirculation